BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang DZ, Wei XD, Wang XP. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma. World J Gastroenterol 2015; 21(15): 4635-4643 [PMID: 25914473 DOI: 10.3748/wjg.v21.i15.4635]
URL: https://www.wjgnet.com/1948-5182/full/v21/i15/4635.htm
Number Citing Articles
1
Jie-Yu Yan, Jin-Long Zhang, Mao-Qiang Wang, Kai Yuan, Yan-Hua Bai, Yan Wang, Hai-Nan Xin, Zhi-Jun Wang, Feng-Yong Liu, Feng Duan, Jin-Xin Fu. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cmAsia-Pacific Journal of Clinical Oncology 2018; 14(4): 300 doi: 10.1111/ajco.12817
2
He Linye, Xia Zijing, Peng Wei, He Chao, Li Chuan, Wen Tianfu. Thymosin alpha-1 therapy improves postoperative survival after curative resection for solitary hepatitis B virus-related hepatocellular carcinomaMedicine 2021; 100(20): e25749 doi: 10.1097/MD.0000000000025749
3
Trevor Hansen, Keith Olsen, Kevin White, Jesse Keller. Retiform Purpura After Transcatheter Arterial Chemoembolization: A Case ReportThe American Journal of Dermatopathology 2018; 40(2): e25 doi: 10.1097/DAD.0000000000000950
4
B. N. Kotiv, I. I. Dzidzava, S. A. Alent’yev, A. V. Smorodsky, K. I. Makhmudov, A. A. Apollonov, S. A. Soldatov, P. N. Zubarev. Complex treatment of hepatocellular carcinoma at early (BCLC-A) and intermediate (BCLC-B) stagesAnnaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2020; 25(2): 55 doi: 10.16931/1995-5464.2020255-66
5
Ramya Ramaswami, David J. Pinato, Keiichi Kubota, Mitsuru Ishizuka, Tadaaki Arizumi, Masatoshi Kudo, Jeong Won Jang, Young Woon Kim, Mario Pirisi, Elias Allara, Rohini Sharma. Prognostic sub-classification of intermediate-stage hepatocellular carcinoma: a multicenter cohort study with propensity score analysisMedical Oncology 2016; 33(10) doi: 10.1007/s12032-016-0827-8
6
Lei Jianyong, Yan Lunan, Li Dajiang, Wang Wentao. Comparison of open liver resection and RFA for the treatment of solitary 3–5-cmhepatocellular carcinoma: a retrospective studyBMC Surgery 2019; 19(1) doi: 10.1186/s12893-019-0663-9